N P Robertson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

N P Robertson

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

Journal of Neurology|January 6, 2010

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathyE A Marsh, C L Hirst, J G Llewelyn, et al.

Multiple Sclerosis and Related Disorders|September 11, 2022

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapiesR Beesley, M Cauchi, L Davies, et al.

Genes and Immunity|June 25, 2010

A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosisM Ban, J L McCauley, R Zuvich, et al.

Pageof 12

Search research articles

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

Journal of Neurology|January 6, 2010

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathyE A Marsh, C L Hirst, J G Llewelyn, et al.

Multiple Sclerosis and Related Disorders|September 11, 2022

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapiesR Beesley, M Cauchi, L Davies, et al.

Genes and Immunity|June 25, 2010

A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosisM Ban, J L McCauley, R Zuvich, et al.

Pageof 12